Stephen P. Squinto, EVP, Chief Global Operations Officer at ALEXION PHARMACEUTICALS INC (ALXN), sold 10,025 shares at $174.95 ($1.7M) on 2014-10-03, disclosed to the SEC on 2014-10-07.
Scheduled sale ($1.7M) by EVP, Chief Global Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $169.95 | 5,100 | $867K | 50.1% |
| 2 | $174.95 | 4,925 | $862K | 49.9% |
| Total | $172.41 avg | 10,025 | $1.7M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $5.0M | — | Filing → |
| ALXN | SELL | 2014-10-28 | $1.1M | — | Filing → |
| ALXN | SELL | 2014-09-26 | $12K | — | Filing → |